PhaseBio Pharmaceuticals, Inc. (PHASQ)
OTCMKTS: PHASQ · Delayed Price · USD
0.0000
0.00 (0.00%)
Apr 16, 2024, 11:18 AM EDT - Market open

PhaseBio Pharmaceuticals Statistics

Total Valuation

PHASQ has a market cap or net worth of $49. The enterprise value is -$2.43 million.

Market Cap 49
Enterprise Value -2.43M

Important Dates

The last earnings date was Wednesday, March 22, 2023.

Earnings Date Mar 22, 2023
Ex-Dividend Date n/a

Share Statistics

Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.18%
Owned by Institutions (%) 4.09%
Float 46.21M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.00
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.47

Current Ratio 0.47
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA 0.19
Debt / FCF n/a
Interest Coverage -90.76

Financial Efficiency

Return on equity (ROE) is -23.71% and return on invested capital (ROIC) is -30.61%.

Return on Equity (ROE) -23.71%
Return on Assets (ROA) 125.58%
Return on Capital (ROIC) -30.61%
Revenue Per Employee $13,633
Profits Per Employee $463,932
Employee Count 60
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax -4.46M
Effective Tax Rate -19.08%

Stock Price Statistics

The stock price has decreased by -99.86% in the last 52 weeks. The beta is 2.08, so PHASQ's price volatility has been higher than the market average.

Beta (1Y) 2.08
52-Week Price Change -99.86%
50-Day Moving Average n/a
200-Day Moving Average 0.00
Relative Strength Index (RSI) 38.64
Average Volume (30 Days) 54

Short Selling Information

Short Interest 2.07M
Short Previous Month 1.47M
Short % of Shares Out n/a
Short % of Float 4.47%
Short Ratio (days to cover) 1.89

Income Statement

In the last 12 months, PHASQ had revenue of $818,000 and earned $27.84 million in profits. Earnings per share was $0.59.

Revenue 818,000
Gross Profit 818,000
Operating Income 29.35M
Pretax Income 26.50M
Net Income 27.84M
EBITDA 28.17M
EBIT 26.23M
Earnings Per Share (EPS) $0.59
Full Income Statement

Balance Sheet

The company has $7.80 million in cash and $5.37 million in debt, giving a net cash position of $2.43 million.

Cash & Cash Equivalents 7.80M
Total Debt 5.37M
Net Cash 2.43M
Net Cash Per Share n/a
Equity / Book Value -117.40M
Book Value Per Share n/a
Working Capital -13.12M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$59.42 million and capital expenditures -$2.40 million, giving a free cash flow of -$61.82 million.

Operating Cash Flow -59.42M
Capital Expenditures -2.40M
Free Cash Flow -61.82M
FCF Per Share -$1.26
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 3,588.21% and 3,402.93%.

Gross Margin 100.00%
Operating Margin 3,588.21%
Pretax Margin 3,239.80%
Profit Margin 3,402.93%
EBITDA Margin 3,443.23%
EBIT Margin 3,206.06%
FCF Margin -7,557.70%

Dividends & Yields

PHASQ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.49%
Shareholder Yield -2.49%
Earnings Yield 56,808,018.37%
FCF Yield -126,167,346.94%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

PHASQ has an Altman Z-Score of -23.27 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -23.27
Piotroski F-Score 3